PARK — Park Dental Partners, Inc. Common Stock

Summary of Park Dental Partners Q4 2025 Earnings Call

1. Key Financial Results and Metrics:

• Q4 Revenue: $61.2 million, a 7.5% year-over-year increase.
• Full-Year Revenue: $244.5 million, reflecting 6.4% growth.
• General Practice Revenue: $44.7 million (up 6.2%), while Multi-Specialty Revenue reached $16.5 million (up 11.3%).
• Same Practice Revenue Growth: 5.8% for the full year and 6.3% in Q4.
• Adjusted EBITDA: Specific figures not disclosed, but the company expects it to range from $21 million to $23 million for 2026.
• Patient Retention Rate: High at 89.9%.
• Operating Cash Flows: $17.6 million for 2025.
• Long-term Debt: $10.1 million, down $1.9 million from the previous year.

2. Strategic Updates and Business Highlights:

• Launched an employee stock purchase plan to enhance team engagement.
• Focused on a growth strategy that includes adding doctors, acquiring practices, and opening new locations.
• Entered Arizona market with a de novo practice and three acquisitions in 2025.
• Investments in technology included implementing an AI tool (Overjet) for radiograph analysis and upgrading workforce management systems.
• Continued emphasis on clinical leadership and doctor engagement in governance.

3. Forward Guidance and Outlook:

• 2026 Revenue Guidance: Expected to be between $254 million and $258 million.
• Same Practice Revenue Growth: Projected at 3.5% to 5%.
• Adjusted EBITDA Guidance: Expected to be 8.3% to 8.9% of revenue.
• Plans to continue disciplined M&A activity and expand into new markets.

4. Bad News, Challenges, or Points of Concern:

• IPO Costs: One-time IPO transaction costs of $2.7 million impacted G&A expenses.
• Share-Based Compensation: Non-cash expenses of $8.8 million related to pre-IPO shares affected earnings per share.
• Increased Public Company Costs: Anticipated additional costs of $400,000 to $500,000 per quarter for public reporting.
• Sales Cycle Variability: Length of the sales cycle for acquisitions can vary significantly, which may impact growth predictability.

5. Notable Q&A Insights:

• The M&A pipeline is robust, with a mix of single and multi-doctor practice opportunities.
• The timeline for integrating acquired practices varies; some can achieve operational efficiency in 3 months, while others may take up to 18 months.
• The company is not currently looking to sell its technology externally but sees it as a competitive advantage in attracting new practices.
• Management emphasized a disciplined approach to acquisitions, focusing on cultural fit and long-term value creation.

Overall, Park Dental Partners reported strong financial performance in 2025, highlighted by solid revenue growth and strategic investments in technology and human capital. The company is optimistic about future growth, although it faces challenges related to IPO costs and the unpredictability of acquisition timelines.